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Background
The viral evolution of HIV-1 and its escape to autolo-
gous neutralizing antibodies (Nabs) during the early
years of infection have been analyzed in depth. In con-
trast, little is known about neither the long-term evolu-
tion of the virus in patients who developed broadly
Nabs (bNabs) nor the mechanism of escape in presence
of these bNabs.
Methods
We have studied the viral population infecting an HIV-1
infected long term non progressor (LTNP) who had devel-
oped Nabs toward all tier 2/3 viruses (6 clades) tested,
9 years after infection, and was then followed up over
7 years. Sixty-nine env clones issued from sequential
blood samples collected from 9 years to 16 years post-
infection were obtained. Thirteen infectious clones repre-
sentative of the genetic diversity of variants present at the
different time-points were selected. Pseudotyped viruses
harboring these different envelopes were generated and
their sensitivity to neutralization was analyzed.
Results
Evidence of ongoing viral evolution was found, supported
by both the phylogenetic analyses that showed a continu-
ous diversification and an increasing divergence over-
time. The mean autologous neutralization titers of the
sequential sera toward the 13 env variants significantly
increased during the period of late follow-up. The env
pseudoviruses displayed a broad range of sensitivity to
the autologous sera, with the most resistant variant iden-
tified at the last visit suggesting that it represented a late
emerging escape variant. We identified 5 amino acids
substitutions that appeared associated with escape to
bNabs. They were V319I/S, R/K355T, R/W429G, Q460E
and G/T463E, in V3, C3 and V5 regions.
Conclusion
This study showed that HIV-1 may continue to evolve in
presence of both broadly neutralizing antibodies and
increasing autologous neutralizing activity more than
10 years post-infection. Such material may provide oppor-
tunities to reveal the molecular determinants of escape of
HIV-1 to highly potent broadly neutralizing antibodies.
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